The evolution to hepta-refractory myeloma involves sequential loss of CD38, BCMA and GPRC5D.
Saved in:
| Title: | The evolution to hepta-refractory myeloma involves sequential loss of CD38, BCMA and GPRC5D. |
|---|---|
| Authors: | Riedhammer C; Department of Internal Medicine 2, University Hospital of Würzburg, Würzburg, Germany., Truger M; MLL Munich Leukemia Laboratory, Munich, Germany., Lee H; Arnie Charbonneau Cancer Institute, University of Calgary, Calgary, AB, Canada., Leypoldt LB; Department of Hematology, Oncology and Bone Marrow Transplantation With Section of Pneumology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.; Mildred Scheel Early Career Center, University Medical Center Hamburg-Eppendorf, Hamburg, Germany., Meggendorfer M; MLL Munich Leukemia Laboratory, Munich, Germany., Hutter S; MLL Munich Leukemia Laboratory, Munich, Germany., Müller H; MLL Munich Leukemia Laboratory, Munich, Germany., Mersi J; Department of Internal Medicine 2, University Hospital of Würzburg, Würzburg, Germany., Kadel SK; Department of Internal Medicine 2, University Hospital of Würzburg, Würzburg, Germany., Buchwald T; Department of Internal Medicine 2, University Hospital of Würzburg, Würzburg, Germany., Kosch R; Department of Hematology, Oncology and Bone Marrow Transplantation With Section of Pneumology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany., Helal M; Mildred Scheel Early Career Center, University Hospital Würzburg, Würzburg, Germany., Afrin N; Mildred Scheel Early Career Center, University Hospital Würzburg, Würzburg, Germany., Rosenwald A; Institute of Pathology, University of Würzburg, Würzburg, Germany., Gerhard-Hartmann E; Institute of Pathology, University of Würzburg, Würzburg, Germany., Brioli A; Department of Internal Medicine C, University Hospital of Greifswald, Greifswald, Germany.; Hannover Medical School, Clinic for Hematology, Hemostaseology, Oncology and Stem Cell Transplantation, Hannover, Germany., Krönke J; Department of Internal Medicine C, University Hospital of Greifswald, Greifswald, Germany., Haferlach T; MLL Munich Leukemia Laboratory, Munich, Germany., Haferlach C; MLL Munich Leukemia Laboratory, Munich, Germany., Weisel KC; Department of Hematology, Oncology and Bone Marrow Transplantation With Section of Pneumology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany., Neri P; Arnie Charbonneau Cancer Institute, University of Calgary, Calgary, AB, Canada., Einsele H; Department of Internal Medicine 2, University Hospital of Würzburg, Würzburg, Germany., Kortüm KM; Department of Internal Medicine 2, University Hospital of Würzburg, Würzburg, Germany., Waldschmidt JM; Department of Internal Medicine 2, University Hospital of Würzburg, Würzburg, Germany., Bahlis N; Arnie Charbonneau Cancer Institute, University of Calgary, Calgary, AB, Canada., Weinhold N; Heidelberg Myeloma Center, Department of Medicine V, University Hospital Heidelberg, Medical Faculty, Heidelberg University, Heidelberg, Germany.; Clinical Cooperation Unit Molecular Hematology/Oncology, Department of Internal Medicine V, Heidelberg University Hospital, Heidelberg University and German Cancer Research Center (DKFZ), Heidelberg, Germany., Rasche L; Department of Internal Medicine 2, University Hospital of Würzburg, Würzburg, Germany. Rasche_L@ukw.de.; Mildred Scheel Early Career Center, University Hospital Würzburg, Würzburg, Germany. Rasche_L@ukw.de. |
| Source: | Leukemia [Leukemia] 2026 Apr; Vol. 40 (4), pp. 730-738. Date of Electronic Publication: 2026 Feb 17. |
| Publication Type: | Journal Article; Multicenter Study |
| Journal Info: | Publisher: Nature Publishing Group, Specialist Journals Country of Publication: England NLM ID: 8704895 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1476-5551 (Electronic) Linking ISSN: 08876924 NLM ISO Abbreviation: Leukemia Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
